122 related articles for article (PubMed ID: 26068633)
1. Symptomatic cardiac metastasis responding to pazopanib in a patient with renal cell carcinoma.
Behzadigohar R; Rosenthal MA; Tran B
Can J Urol; 2015 Jun; 22(3):7824-6. PubMed ID: 26068633
[TBL] [Abstract][Full Text] [Related]
2. Recurrent renal cell carcinoma presenting as a solitary left ventricular mass.
Wilde L; Mehrotra P; Hoffman-Censits J
Can J Urol; 2017 Dec; 24(6):9145-9147. PubMed ID: 29260644
[TBL] [Abstract][Full Text] [Related]
3. Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: impact of TKIs' antiangiogenic activity.
Schinzari G; Monterisi S; Signorelli D; Cona MS; Cassano A; Danza F; Barone C
Tumori; 2014; 100(6):e298-300. PubMed ID: 25688515
[TBL] [Abstract][Full Text] [Related]
4. Prolonged survival of a patient with papillary renal cell carcinoma and brain metastases using pazopanib.
Jacobs C; Kim DW; Straka C; Timmerman RD; Brugarolas J
J Clin Oncol; 2013 Mar; 31(7):e114-7. PubMed ID: 23319695
[No Abstract] [Full Text] [Related]
5. Chromophobe renal cell carcinoma with sarcomatoid dedifferentiation treated with pazopanib: a case report.
Matrana MR; Ng C; Rao P; Lim ZD; Tannir NM
Clin Genitourin Cancer; 2011 Dec; 9(2):137-9. PubMed ID: 21831725
[No Abstract] [Full Text] [Related]
6. Renal cell cancer metastases to esophagus and stomach successfully treated with radiotherapy and pazopanib.
Cabezas-Camarero S; Puente J; Manzano A; Corona JA; González-Larriba JL; Bernal-Becerra I; Sotelo M; Díaz-Rubio E
Anticancer Drugs; 2015 Jan; 26(1):112-6. PubMed ID: 25075797
[TBL] [Abstract][Full Text] [Related]
7. Successful re-administration of Pazopanib in a patient with metastatic renal cell carcinoma and a history of Pazopanib-induced nephrotic syndrome: a case report.
Jeon SY; Lee NR; Yim CY
BMC Nephrol; 2019 Jan; 20(1):1. PubMed ID: 30606155
[TBL] [Abstract][Full Text] [Related]
8. Cardiac metastasis of renal cell carcinoma without inferior vena cava involvement: case report.
Topçuoğlu M; Yeşilkaya Y; Kılınçer A
Turk Kardiyol Dern Ars; 2013 Mar; 41(2):154-6. PubMed ID: 23666305
[TBL] [Abstract][Full Text] [Related]
9. Pazopanib in renal cell carcinoma.
Sternberg CN
Clin Adv Hematol Oncol; 2010 Apr; 8(4):232-3. PubMed ID: 20505644
[No Abstract] [Full Text] [Related]
10. Pazopanib for the treatment of metastatic renal cell carcinoma.
Pick AM; Nystrom KK
Clin Ther; 2012 Mar; 34(3):511-20. PubMed ID: 22341567
[TBL] [Abstract][Full Text] [Related]
11. Nursing considerations for patients receiving pazopanib for renal cell carcinoma.
Becze E
ONS Connect; 2012 Feb; 27(2):16-7. PubMed ID: 22375508
[No Abstract] [Full Text] [Related]
12. Uveal metastasis and myasthenia gravis in a patient with recurrent renal cell carcinoma treated with pazopanib.
Jebb A; Hadden P; Broom RJ
Clin Genitourin Cancer; 2014 Aug; 12(4):e143-6. PubMed ID: 24656526
[No Abstract] [Full Text] [Related]
13. Pazopanib for the treatment of renal cancer.
Al-Marrawi MY; Rini B
Expert Opin Pharmacother; 2011 May; 12(7):1171-89. PubMed ID: 21470066
[TBL] [Abstract][Full Text] [Related]
14. Nursing considerations with pazopanib therapy: focus on metastatic renal cell carcinoma.
Bourdeanu L; Twardowski P; Pal SK
Clin J Oncol Nurs; 2011 Oct; 15(5):513-7. PubMed ID: 21951737
[TBL] [Abstract][Full Text] [Related]
15. Pazopanib as third line therapy for metastatic renal cell carcinoma: clinical efficacy and temporal analysis of cytokine profile.
Pal SK; Hossain DM; Zhang Q; Frankel PH; Jones JO; Carmichael C; Ruel C; Lau C; Kortylewski M
J Urol; 2015 Apr; 193(4):1114-21. PubMed ID: 25286010
[TBL] [Abstract][Full Text] [Related]
16. Early and prolonged response to pazopanib in a patient with multiple metastases from renal cell carcinoma: a case report.
Biasco E; Antonuzzo A; Cianci C; Derosa L; Marconcini R; Farnesi A; Galli L
Tumori; 2014; 100(3):e83-6. PubMed ID: 25076257
[TBL] [Abstract][Full Text] [Related]
17. [Pazopanib (Votrient) in the management of renal cell cancer and soft tissue sarcomas].
Gennigens C; Jerusalem G
Rev Med Liege; 2012; 67(7-8):437-42. PubMed ID: 22984765
[TBL] [Abstract][Full Text] [Related]
18. [A rare form of heart metastasis: hypernephroma. Successful surgical treatment].
Minale C; Ulbricht LJ; Höler H; Köbberling J; Cramer BM; Schubert GE
Z Kardiol; 1995 Aug; 84(8):643-7. PubMed ID: 7571771
[TBL] [Abstract][Full Text] [Related]
19. Good tolerability, long-term survival and easy management of side effects in a patient with metastatic renal cell carcinoma treated with pazopanib.
Frascaroli M; Di Cesare P
Tumori; 2014; 100(6):e301-4. PubMed ID: 25688516
[TBL] [Abstract][Full Text] [Related]
20. Posterior reversible encephalopathy syndrome induced by pazopanib for renal cell carcinoma.
Asaithambi G; Peters BR; Hurliman E; Moran BP; Khan AS; Taylor RA
J Clin Pharm Ther; 2013 Apr; 38(2):175-6. PubMed ID: 23210935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
